Related Experiment Video
Updated: Mar 16, 2026

Identification of Cyclin-dependent Kinase 1 Specific Phosphorylation Sites by an In Vitro Kinase Assay
Published on: May 3, 2018
PKM2 dephosphorylation by Cdc25A promotes the Warburg effect and tumorigenesis
Ji Liang1,2, Ruixiu Cao1,2, Yajuan Zhang1,2
1Key Laboratory of Systems Biology, CAS Center for Excellence in Molecular Cell Science, Institute of Biochemistry and Cell Biology, Shanghai Institutes for Biological Sciences, Chinese Academy of Sciences, Shanghai 200031, China.
Abstract:
Many types of human tumour cells overexpress the dual-specificity phosphatase Cdc25A. Cdc25A dephosphorylates cyclin-dependent kinase and regulates the cell cycle, but other substrates of Cdc25A and their relevant cellular functions have yet to be identified. We demonstrate here that EGFR activation results in c-Src-mediated Cdc25A phosphorylation at Y59, which interacts with nuclear pyruvate kinase M2 (PKM2). Cdc25A dephosphorylates PKM2 at S37, and promotes PKM2-dependent β-catenin transactivation and c-Myc-upregulated expression of the glycolytic genes GLUT1, PKM2 and LDHA, and of CDC25A; thus, Cdc25A upregulates itself in a positive feedback loop. Cdc25A-mediated PKM2 dephosphorylation promotes the Warburg effect, cell proliferation and brain tumorigenesis. In addition, we identify positive correlations among Cdc25A Y59 phosphorylation, Cdc25A and PKM2 in human glioblastoma specimens. Furthermore, levels of Cdc25A Y59 phosphorylation correlate with grades of glioma malignancy and prognosis. These findings reveal an instrumental function of Cdc25A in controlling cell metabolism, which is essential for EGFR-promoted tumorigenesis.
Insights
Cdc25A phosphatase promotes brain tumor growth by regulating cell metabolism and pyruvate kinase M2 (PKM2) activity. Its phosphorylation at Y59 correlates with glioma malignancy and poor prognosis.
Area of Science:
- Oncology
- Molecular Biology
- Biochemistry
Background:
- Human tumor cells frequently overexpress Cdc25A, a phosphatase regulating the cell cycle.
- While Cdc25A's role in cell cycle regulation is known, its other substrates and functions remain largely uncharacterized.
Purpose of the Study:
- To investigate the role of Cdc25A in tumorigenesis beyond cell cycle regulation.
- To identify novel substrates and functions of Cdc25A in cancer, particularly in relation to EGFR signaling and cell metabolism.
Main Methods:
- Investigated the interaction between Cdc25A, EGFR, c-Src, and pyruvate kinase M2 (PKM2).
- Analyzed Cdc25A-mediated phosphorylation of PKM2 and its downstream effects on gene expression and cellular processes.
- Examined human glioblastoma specimens to correlate Cdc25A Y59 phosphorylation with tumor grade and patient prognosis.
Main Results:
- EGFR activation leads to c-Src-mediated Cdc25A phosphorylation at Y59, which then interacts with PKM2.
- Cdc25A dephosphorylates PKM2 at S37, promoting β-catenin transactivation and c-Myc-driven expression of glycolytic genes (GLUT1, PKM2, LDHA).
- This interaction creates a positive feedback loop, upregulating CDC25A and promoting the Warburg effect, cell proliferation, and brain tumorigenesis.
Conclusions:
- Cdc25A plays a critical role in controlling cell metabolism, essential for EGFR-promoted tumorigenesis.
- Cdc25A-mediated PKM2 dephosphorylation drives the Warburg effect and supports tumor growth.
- Cdc25A Y59 phosphorylation is a potential biomarker for glioma malignancy and prognosis.
More Related Videos
Related Concept Videos
Abnormal Proliferation
Inhibition of Cdk Activity
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
PI3K/mTOR/AKT Signaling Pathway
DNA Damage can Stall the Cell Cycle
DNA Damage Can Stall the Cell Cycle

